AXSM Return to supply

NASDAQ:AXSM   Axsome Therapeutics, Inc
Every trader worth their salt needs to trade in at least one crappy biotech.
I say trade, but chances are you will end up an investor... just like those guys who bought at $100.

AXSM has a very nice pipeline. The drop was due to incorrect FDA filing. Perhaps the clean up their act and release some drugs for all the kids (and elderly) to enjoy.